This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Useful Model for Human Keratoconjunctivitis Sicca: Treatment With Cyclosporine Eye Drops

Renee L. Kaswan, DVM, MS; Mary-Alice Salisbury, DVM; Daniel A. Ward, DVM

Arch Ophthalmol. 1989;107(8):1210-1216.

Abstract
• Thirty-six sequential cases of canine keratoconjunctivitis sicca (KCS) were treated with ophthalmic cyclosporine. The effects of topical cyclosporine were twofold: (1) cyclosporine increased tear production by 5 mm/min or greater in all cases of spontaneous KCS having an initial Schirmer's Tear Test value greater than 2 mm /min and in 59% of eyes with an initial Schirmer's Tear Test value of 0 to 2 mm/min, and (2) cyclosporine caused marked regression of chronic corneal neovascularization and granulation even in eyes in which lacrimation failed to improve. Additional benefits of topical cyclosporine were reduced mucopurulent conjunctivitis, rapid healing of nonhealing corneal ulcers, and reduced dependence on frequent topical treatments of KCS. Twelve normal beagles treated with topical cyclosporine also had a reversible increase in lacrimation compared with baseline or placebo control-treated dogs.

Author Affiliations
From the Department of Small Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens.

Footnotes
Accepted for publication January 24,1989.

Reprint requests to the College of Veterinary Medicine, University of Georgia, Athens, GA 30602 (Dr Kaswan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurologic Evaluation of Acute Lacrimomimetic Effect of Cyclosporine in an Experimental Rabbit Dry Eye Model
Toshida et al.
IOVS 2009;50:2736-2741.
ABSTRACT | FULL TEXT  

Protective Effect of D-{beta}-Hydroxybutyrate on Corneal Epithelia in Dry Eye Conditions through Suppression of Apoptosis
Nakamura et al.
IOVS 2003;44:4682-4688.
ABSTRACT | FULL TEXT  

A Mouse Model of Keratoconjunctivitis Sicca
Dursun et al.
IOVS 2002;43:632-638.
ABSTRACT | FULL TEXT  

Effect of Cyclosporine on Conjunctival Mucin in a Canine Keratoconjunctivitis Sicca Model
Moore et al.
IOVS 2001;42:653-659.
ABSTRACT | FULL TEXT  

Improvement of Lacrimal Function by Topical Application of CyA in Murine Models of Sjogren's Syndrome
Tsubota et al.
IOVS 2001;42:101-110.
ABSTRACT | FULL TEXT  

Analysis of Topical Cyclosporine Treatment of Patients With Dry Eye Syndrome: Effect on Conjunctival Lymphocytes
Kunert et al.
Arch Ophthalmol 2000;118:1489-1496.
ABSTRACT | FULL TEXT  

Suppression of Corneal Neovascularization With Cyclosporine
Lipman et al.
Arch Ophthalmol 1992;110:405-407.
ABSTRACT